LBC
CVS icon

Leigh Baldwin & Co’s CVS Health CVS Stock Holding History

Leigh Baldwin & Co’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$589K Buy
8,201
+32
+0.4% +$2.46K 0.38% 64
2025
Q4 		$648K Sell
8,169
-1,003
-11% -$79.1K 0.43% 57
2025
Q3 		$691K Sell
9,172
-481
-5% -$33K 0.39% 66
2025
Q2 		$666K Buy
9,653
+3,105
+47% +$204K 0.44% 65
2025
Q1 		$444K Buy
6,548
+308
+5% +$18.4K 0.36% 76
2024
Q4 		$280K Buy
+6,240
New +$350K 0.24% 122

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Leigh Baldwin & Co's CVS Position: Q1 2026 in Review

Leigh Baldwin & Co increased its CVS Health (CVS) stake by 0.39% in Q1 2026, buying an estimated $2.46K and bringing the position to 8,201 shares worth $589K. The position accounts for 0.38% of the portfolio, ranked #64.

Leigh Baldwin & Co first reported a position in CVS in Q4 2024 and has held it in 6 quarters since. The position peaked at $691K in Q3 2025. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Leigh Baldwin & Co held 8,201 shares of CVS Health worth $589K as of Q1 2026.
  • Leigh Baldwin & Co bought 32 CVS Health shares in Q1 2026, an estimated $2.46K.
  • CVS Health made up 0.38% of Leigh Baldwin & Co's portfolio in Q1 2026, its #64 holding.
  • Leigh Baldwin & Co first reported a position in CVS Health in Q4 2024 and has held it in 6 quarters since.
  • Leigh Baldwin & Co's CVS Health position peaked at $691K in Q3 2025.
  • 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Leigh Baldwin & Co's 13F filing for Q1 2026, filed 20 May 2026.